As Seen On TV: FDA Generic Drug Import Ban

Sept. 16, 2008— -- The Food and Drug Administration announced today that it will block the import of some widely used generic drugs made by Ranbaxy Laboratories Ltd., a major manufacturer in India, citing concerns about poor quality control in their production. The FDA issued two warning letters and an import alert for generic drugs produced at two of Ranbaxy's plants. People taking any of 30 generic medications, such as the generics of Cipro, Alavert and Claritin, could be affected by today's alert.